13D/13G Filings - XORTX Therapeutics Inc. (XRTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
5:04 pm
Purchase
2024-12-31 13G XORTX Therapeutics Inc.
XRTX
Armistice Capital, LLC 346,807
9.990%
177,017increase
(+104.26%)
Filing
History
2024-02-14
3:03 pm
Purchase
2023-12-31 13G XORTX Therapeutics Inc.
XRTX
Armistice Capital, LLC 169,790
4.990%
169,790increase
(New Position)
Filing
History
2023-02-14
1:48 pm
Purchase
2022-12-31 13G XORTX Therapeutics Inc.
XRTX
Armistice Capital, LLC 18,550
9.990%
18,550increase
(New Position)
Filing
History